Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The standard of care for patients with stage III non-small cell lung cancer is concurrent chemoradiotherapy followed by maintenance durvalumab based on outcomes from the PACIFIC trial. The efficacy of this regimen in a real-world population has not been extensively studied. We found...

Descripción completa

Detalles Bibliográficos
Autores principales: Sankar, Kamya, Bryant, Alex K., Strohbehn, Garth W., Zhao, Lili, Elliott, David, Moghanaki, Drew, Kelley, Michael J., Ramnath, Nithya, Green, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833364/
https://www.ncbi.nlm.nih.gov/pubmed/35158881
http://dx.doi.org/10.3390/cancers14030614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833364/
https://www.ncbi.nlm.nih.gov/pubmed/35158881
http://dx.doi.org/10.3390/cancers14030614

Ejemplares similares